Diagnostic performance of magnetic resonance imaging and targeted biopsy results in men with indwelling urinary catheters: A propensity score matched study.

IF 2 4区 医学 Q3 UROLOGY & NEPHROLOGY
Tomer Bashi, Adi Kidron, Ziv Savin, Amihay Nevo, Sophie Barnes, Ofer Yossepowitch, Roy Mano, Snir Dekalo
{"title":"Diagnostic performance of magnetic resonance imaging and targeted biopsy results in men with indwelling urinary catheters: A propensity score matched study.","authors":"Tomer Bashi, Adi Kidron, Ziv Savin, Amihay Nevo, Sophie Barnes, Ofer Yossepowitch, Roy Mano, Snir Dekalo","doi":"10.5489/cuaj.9194","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>We sought to evaluate multiparametric magnetic resonance imaging (mpMRI) findings and biopsy results in men with an indwelling catheter undergoing prostate cancer screening. mpMRI is central to the evaluation of prostate cancer. Little is known as to the effect of an indwelling urinary catheter on prostate mpMRI findings and the results of subsequent biopsies.</p><p><strong>Methods: </strong>We retrospectively reviewed 5820 mpMRI exams performed from 2017-2023. Forty-eight patients underwent mpMRI with indwelling urinary catheter. Using propensity score matching, patients were matched 1:1 for age, pre-biopsy prostate-specific antigen (PSA), and prostate volume. Clinical characteristics, mpMRI findings, and targeted biopsy results were compared between the groups.</p><p><strong>Results: </strong>After propensity score matching, clinical characteristics of the study groups did not differ significantly. Prostate Imaging-Reporting & Data System (PI-RADS) distribution did not show a significant difference (p=0.51); PI-RADS ≥3 lesions were identified in 20/48 patients with indwelling catheters (42%) and in 18/50 patients without catheters (36%). Among patients with a PI-RADS score ≥3, clinically significant prostate cancer (CSPC) was identified in 5/20 patients carrying catheters and 6/18 patients without catheters (p=0.152). A higher rate of any cancer was identified in patients without a catheter (67% vs. 35%, p=0.049). PSA >9.79 ng/ml predicted the finding of CSPC in patients carrying urinary catheters with PI-RADS ≥3 lesions.</p><p><strong>Conclusions: </strong>Our findings suggest no significant difference in mpMRI findings and CSPC rates for patients with and without indwelling urinary catheters. Patients carrying urinary catheters suspected to harbor CSPC based on an elevated PSA level should undergo further evaluation, including mpMRI and biopsies when necessary before benign prostatic hyperplasia treatment.</p>","PeriodicalId":50613,"journal":{"name":"Cuaj-Canadian Urological Association Journal","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cuaj-Canadian Urological Association Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5489/cuaj.9194","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: We sought to evaluate multiparametric magnetic resonance imaging (mpMRI) findings and biopsy results in men with an indwelling catheter undergoing prostate cancer screening. mpMRI is central to the evaluation of prostate cancer. Little is known as to the effect of an indwelling urinary catheter on prostate mpMRI findings and the results of subsequent biopsies.

Methods: We retrospectively reviewed 5820 mpMRI exams performed from 2017-2023. Forty-eight patients underwent mpMRI with indwelling urinary catheter. Using propensity score matching, patients were matched 1:1 for age, pre-biopsy prostate-specific antigen (PSA), and prostate volume. Clinical characteristics, mpMRI findings, and targeted biopsy results were compared between the groups.

Results: After propensity score matching, clinical characteristics of the study groups did not differ significantly. Prostate Imaging-Reporting & Data System (PI-RADS) distribution did not show a significant difference (p=0.51); PI-RADS ≥3 lesions were identified in 20/48 patients with indwelling catheters (42%) and in 18/50 patients without catheters (36%). Among patients with a PI-RADS score ≥3, clinically significant prostate cancer (CSPC) was identified in 5/20 patients carrying catheters and 6/18 patients without catheters (p=0.152). A higher rate of any cancer was identified in patients without a catheter (67% vs. 35%, p=0.049). PSA >9.79 ng/ml predicted the finding of CSPC in patients carrying urinary catheters with PI-RADS ≥3 lesions.

Conclusions: Our findings suggest no significant difference in mpMRI findings and CSPC rates for patients with and without indwelling urinary catheters. Patients carrying urinary catheters suspected to harbor CSPC based on an elevated PSA level should undergo further evaluation, including mpMRI and biopsies when necessary before benign prostatic hyperplasia treatment.

男性留置导尿的磁共振成像和靶向活检结果的诊断性能:一项倾向评分匹配的研究。
简介:我们试图评估多参数磁共振成像(mpMRI)的发现和活检结果的男性留置导管接受前列腺癌筛查。mpMRI是评估前列腺癌的核心。关于留置导尿管对前列腺mpMRI检查结果和随后的活检结果的影响,我们知之甚少。方法:回顾性分析2017-2023年5820例mpMRI检查。48例患者行mpMRI留置导尿。使用倾向评分匹配,患者的年龄、活检前前列腺特异性抗原(PSA)和前列腺体积按1:1匹配。比较两组患者的临床特征、mpMRI表现和靶向活检结果。结果:倾向评分匹配后,各组临床特征无显著差异。前列腺影像报告与数据系统(PI-RADS)分布差异无统计学意义(p=0.51);PI-RADS≥3的病变在48例留置导管患者中有20例(42%),在50例无留置导管患者中有18例(36%)。在PI-RADS评分≥3的患者中,有5/20的患者有导管,6/18的患者没有导管,有临床意义的前列腺癌(CSPC) (p=0.152)。无导管患者的任何癌症发生率均较高(67%对35%,p=0.049)。PSA >9.79 ng/ml预测PI-RADS≥3病变患者携带导尿管出现CSPC。结论:我们的研究结果表明,有和没有留置导尿的患者在mpMRI表现和CSPC率上没有显著差异。根据PSA水平升高怀疑携带CSPC的患者应接受进一步的评估,包括mpMRI和活检,必要时再进行良性前列腺增生治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cuaj-Canadian Urological Association Journal
Cuaj-Canadian Urological Association Journal 医学-泌尿学与肾脏学
CiteScore
2.80
自引率
10.50%
发文量
167
审稿时长
>12 weeks
期刊介绍: CUAJ is a a peer-reviewed, open-access journal devoted to promoting the highest standard of urological patient care through the publication of timely, relevant, evidence-based research and advocacy information.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信